Market Flash

In a significant development for the pharmaceutical industry, a comprehensive volume-based procurement list has been announced, incorporating a staggering 1007 medicines.

In a significant collaboration, Syngenta Group, a Chinese company, has joined forces with Agriodor from France to develop an innovative biopesticide aimed at combating the beet aphid, a prominent pest affecting sugar beet crops.

In a recent development, Ukraine has introduced new standards for various food products, including jams, jellies, and chestnut puree.

In a recent development, the European Union (EU) has issued revised regulations pertaining to the import of animals and animal products from third countries.

China: Ten points to note for export pesticide registration only

• pesticides
• Paraquat
• Metsulfuron
• methyl

Chlorantraniliprole, Lufenuron, Validamycin and Oxine-copper were registered in Chinese Chieh-qua for the first time

• Validamycin
• Chlorantraniliprole
• Lufenuron

Mexico has recently encountered a concerning outbreak of highly pathogenic H5N2 avian influenza, according to the latest report from the World Organization for Animal Health (WOAH).

In this article, we will explore the reasons behind India's export ban, examine its impact on various stakeholders, and analyze the potential consequences for the global onion trade.

Turkmenistan, a country located in Central Asia, is making significant efforts to enhance international cooperation in the agricultural sector.

This article provides a comprehensive overview of the latest updates in the field, highlighting the upcoming batch of procurements and the anticipated price reductions for high-value orthopedic and ophthalmic consumables.

In a recent development, two pharmaceutical giants, State Pharmaceutical Holdings (国药控股) and China Resources Pharmaceutical Group (华润医药), have unveiled their latest financial performance for the year 2023.

Varnotech Biopharm, a leading innovative biotech company focused on vaccine research and development, has recently announced the successful completion of its Series B funding round, raising a total of ¥600 million.

Astellas announced the approval and market launch of their Claudin18.2 antibody, Zolbetuximab (Vyloy), for the treatment of advanced gastric cancer in Japan.

NMPA has accepted the market application for a new indication of Saovitinib, a selective MET inhibitor, for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) patients with MET exon 14 skipping mutations.

FastenMaster, a division of OMG, Inc., introduces Deck Frame Coating, a water-based sealant that helps extend the life of your deck by creating a long-lasting moisture barrier.

• FastenMaster

Elementis releases three new rheology additive products, RHEOLATE 644 IF, RHEOLATE 655 IF and RHEOLATE 666 IF.

• Elementis

On March 20, 2024, China approved the registration of four new Prothioconazole technical products, and the registration certificate holders are Jiangsu Suyan., Jiangsu Flagchem, Inner Mongolia NAB, and Shandong Jingbo

• Prothioconazole
• formulation
• technical

In a recent development, several CEOs of multinational medical device companies visited China, indicating a positive outlook for the country's healthcare industry.

Hansoh Pharmaceutical, a renowned pharmaceutical company, has recently announced its remarkable performance for the year 2023.

Mabwell Biotech, a leading pharmaceutical company, has recently made significant strides in expanding its presence in South Asia and Africa.